University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

12-2008

Synergistic Effect of Retinoic Acid, Nerve Growth Factor And
Laminin For Enhanced Neurite Extension
Shrarath Ashwin Sriman
University of Tennessee - Knoxville

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes
Part of the Biomedical Engineering and Bioengineering Commons

Recommended Citation
Sriman, Shrarath Ashwin, "Synergistic Effect of Retinoic Acid, Nerve Growth Factor And Laminin For
Enhanced Neurite Extension. " Master's Thesis, University of Tennessee, 2008.
https://trace.tennessee.edu/utk_gradthes/491

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Shrarath Ashwin Sriman entitled "Synergistic Effect
of Retinoic Acid, Nerve Growth Factor And Laminin For Enhanced Neurite Extension." I have
examined the final electronic copy of this thesis for form and content and recommend that it be
accepted in partial fulfillment of the requirements for the degree of Master of Science, with a
major in Biomedical Engineering.
WEI HE, Major Professor
We have read this thesis and recommend its acceptance:
KENNETH D. KIHM, ROBERTO S. BENSON
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a thesis written by Sharath Ashwin Sriman entitled “Synergistic Effect
of Retinoic Acid, Nerve Growth Factor And Laminin For Enhanced Neurite Extension” I have
examined the final electronic copy of this thesis for form and content and recommend that it be
accepted in partial fulfillment of the requirements for the degree of Master of Science in
Biomedical Engineering.
_______________________________
DR. WEI HE, MAJOR PROFESSOR
We have read this thesis
and recommend its acceptance:

__________________________
DR. WEI HE

__________________________
DR. KENNETH D. KIHM

__________________________
DR. ROBERTO S. BENSON
Accepted for the council:
____________________________
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School

SYNERGISTIC EFFECT OF RETINOIC ACID, NERVE GROWTH FACTOR AND
LAMININ FOR ENHANCED NEURITE EXTENSION

A Thesis Presented for
the Master of Science
Degree
The University of Tennessee, Knoxville

Sharath Ashwin Sriman
December 2008

Copyright © 2008 by Sharath Ashwin Sriman
All rights reserved.

ACKNOWLEDGEMENTS

I would like to thank everyone who was helped me make this thesis a success. I would first like
to express my gratitude to my advisor Dr. Wei He, for her valuable insight and guidance
throughout the course of this work. I admire her vast knowledge, methodical and diligent
approach to research. I am really proud to have worked under her and submit this thesis as a
token of my appreciation.
I would like to thank my committee members Dr. Kenneth D. Kihm and Dr. Roberto S. Benson
for readily accepting to be a part of the committee on a short notice. I would like to thank both of
them for the immense warmth and comfort they provided. I would like to thanks Dr. Kihm for
providing us the microscope to do the imaging.
I would also like to express my gratitude to Dr. Judith Grizzle for providing us with a never
ending supply of chicken eggs and for her valuable inputs on handling them. I would also like to
thank Chuck and Illatoi for helping me with the microscope handling.
I am extremely grateful to my parents and to my sister for being a constant source of support not
only through this project, but throughout my life. I consider myself lucky to be a part of this
family and I hope to do justice to the amount of dedication and love they have showered upon
me.
I would especially like to thank my friend Abhaya for volunteering for the blindfold study at
short notice. She has been a never ending source motivation for me, always pushing me ahead
and being supportive when I needed it most. I would also like to thank Simi Mohanty and
Harishwaran for their help with the image analysis.
iv

ABSTRACT

Peripheral Nerve Injury is one of the most common and serious traumatic injuries. About
300,000 cases of peripheral nerve injury are reported annually in Europe and another 50,000
procedures performed annually in the United States. Peripheral nerve injury can lead to lifelong
disability and also death in severe cases. Repair techniques remain a major challenge because of
lack of efficient regeneration. Though techniques like autografts are highly efficient, they face a
lot of drawbacks. Alternate methods focus on the use of growth supporting and enhancement
components in nerve guidance channels. Current research necessitates the use of a combination
of compounds for enhanced nerve growth. In this thesis we study the combined effect of Nerve
Growth Factor (NGF), laminin and Retinoic acid (RA) on nerve growth. This study is aimed at
attaining higher efficiency in nerve growth by using a combination of compounds not tested
together before. We expect to see an enhanced outgrowth, supposedly caused by the synergistic
effect of these components, which will be greater than the outgrowth caused when these
compounds are used individually or in combination with another compound. Chick dorsal root
ganglion cells were cultured for 36 hrs in the presence of 50ng/ml NGF, 50µg/ml laminin and
1µM RA, either used individually, or in combination with another compound, or synergistically.
The efficiency of each condition was determined based on neurite extension and area of
outgrowth. The triple component system produced significantly greater neurite extension and
outgrowth compared to all when the compounds are used individually or in combination with
one another. The neurite length in the triple component system was 5 fold that of control whereas
the area of outgrowth was as high as 60 times that of control. This enhanced neurite growth
achieved will pave way for efficient nerve guidance channels development.
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CHAPTER 1: INTRODUCTION

Statement of the Problem:
Peripheral nerve injury is one of the most serious clinical issues, accounting to about
2.8% of all traumatic injuries, out of which 65% is found to occur in the upper extremity and that
too involving radial nerves. Commonly seen in males in the age group of 18-25, most injuries are
caused by motor vehicle and industrial accidents. Data from the National Centre for health
statistics show that there were more than 50,000 peripheral nerve repair procedure performed in
the United States in the year 1995 [1]. In Europe there are well over 300,000 cases of peripheral
nerve injury reported annually [2].
After injury, the axons spontaneously regenerate over relatively shorter gaps (< 5mm).
Occurrence of regeneration does not by itself mean functional recovery and this may primarily
be due to the axons regenerating toward non targets. When the gap is greater than 1cm, there is a
lack of guidance cues for the generating axons and they end up growing backward into the
proximal nerve stump, or enter a non target endonerium or end up forming neuromas [3, 4].
Failure by the injured axons to regenerate and its degeneration over time may eventually lead to
atrophy of the target [5]. These are the two primary concerns regarding peripheral nerve
regeneration. Any tissue engineering technique employed to aid nerve regeneration must have a
directional cue so as to guide the sprouting axons towards the target site, and at the same time
must be time efficient so as to prevent loss of function or atrophy of target tissue.
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It is important that any tissue engineering approach aimed at resolving peripheral nerve
regeneration should be able to match the gold standards set by autografts for smaller injuries.
Any alternate approach should not only be able to match the performance of the autografts but
should also be able to resolve issues arising with autogratfs. Though autografts are considered as
the gold standard of nerve regeneration, tissue engineering provides ample opportunity to reach
higher standards and match intact nerves.
Hypothesis
We propose that by using a combination of Nerve Growth Factor (NGF), laminin and
retinoic acid (RA) we would be able to attain maximum neurite outgrowth for a given time
period. We expect an enhanced outgrowth, supposedly caused by the synergistic effect of these
components, which will be greater than the outgrowth caused when these compounds are used
individually or in combination with any one another compound. We also propose to study the
effect of a delayed release model and its effect on nerve outgrowth, from which we plan to
acquire information about the effect of time dependent release on the nerve outgrowth.
Objective
The objective of this study is not to find a final solution for peripheral nerve injury, but
rather an improvisation towards the goal of successful nerve regeneration. Through this study,
we aim to attain faster nerve growth within a given period of time by using a mixture of
compounds that can act synergistically to enhance growth. Through the delayed release study,
we would be able to set a framework for future work on time dependent release for even more
synergistically effective growth.
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CHAPTER 2: LITERATURE REVIEW

2.1. Peripheral Nerve Injury
2.1.1. An introduction to Peripheral Nerve Injury
Injury to the peripheral nervous system (PNS) is one of the most common and serious
clinical conditions leading to the loss of motor function or sensory function or both. Based on his
study of 5777 trauma patients, Noble et al [6] outlines that peripheral nerve injury accounts for
almost 2.8% of traumatic injuries, mostly caused due to motor injuries and in many cases leading
to lifelong disabilities. Other common types of injuries leading to peripheral nerve damage are
penetrating injury, crash, traction, ischemia, laceration by sharp objects [7, 8].
Though a complete understanding of the anatomy of the nerve is not essential for the
present study, a basic understanding would help gain an insight of the pathophysiology of
peripheral nerves. This is required for better understanding of nerve injuries and to make a
knowledgeable approach towards nerve injury repair. Figure 1 illustrates the anatomy of a
peripheral nerve.
A nerve basically consists of individual myelinated axons and groups of unmyelinated
axons surrounded by an endonerium. The perinerium surrounds the fascicles which is a
collection of axons. The fascicles combine to form the nerve trunk. The external epinerium
covers the nerve trunk. The perineurium and epineurium are circumferential oriented whereas the
endoneurium is longitudinally oriented [9].
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Figure 1: Anatomy of a nerve. Adapted from [9, 10]
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Table 1 Classification of nerve injury. Adapted from [10]

Seddon
[11]

Neurapraxia

Sunderland [9]

First Degree

State of Injured Site

Occurrence of segmental demyelination

The axons are severed, but the endonerium remains intact,
Second Degree

and there are optimal chances for regeneration under this
condition

Axonotmesis
Discontinuity of axons and the endoneurial tube, but the
Third Degree

arrangement of the perinerium and fascicular arrangements
are preserved
Neuroma occurs. There is a loss of continuity of the axons,

Fourth Degree

perinerium, fascicle and the endoneurial tube. The
epinerium is still intact

Neurotmesis

Fifth Degree

Continuity of the entire nerve trunk is lost
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The two major classifications of peripheral nerve injuries have been given by Seddon
[11] and Sunderland [9]. The table above is a comparison between the two classifications.
Most of these patients acquire lifelong disability due to nerve injury [6]. Injuries to
peripheral nerves may also occur due to trauma or surgical procedures, which can result in the
loss of muscle function, impaired sensation, and/or painful neuropathies [12, 13]. Peripheral
nerve injuries (PNIs) lead to reduced muscular recruitment and sensation. It also disrupts
coordination among organs through changes in both the PNS and the CNS.
2.1.2. Current Strategies to Treat Peripheral Nerve Injury
In cases where the gap caused due to injury is small, coaptation by suturing the ends of
the severed nerves is followed. For gaps larger than 5mm, coaptation cannot be implemented and
autograft is used. Autograft is the process in which an uninjured healthy nerve is taken from
another part of the body, usually called the donor site and then used in the injured site.
Autografts are considered the ‘gold standard’ for nerve repair, but pose a few disadvantages like
limited availability, loss of function in the donor site, size mismatch, additional surgery time,
potential neuroma formation and also frequent unsatisfactory results [12, 14]. Allografts and
Xenografts have also been used but with less success. These techniques often have to address the
issues of immuno-suppression and are almost always affected by graft rejection [5]. Such
limitations and disadvantages have lead to the search for alternate methodologies such as
artificial nerve grafts, tissues engineered nerve conduits, etc.
Earlier attempts in using these artificial grafts to aid nerve regeneration were basically
studies that involved empty or silane-filled silicone tubes. Although these synthetic grafts had a
few advantages compared to natural grafts, their use was restricted in many ways. Most of them
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could be effectively used only up to a distance of up to 1cm [15]. They were often non
biodegradable and were considered foreign and thus enveloping scar tissue [16, 17]. These
disadvantages led to the development of bioresorbable grafts. These grafts were not only
biodegradable, but were also effective in encapsulating and providing guidance channels to the
growing axons [18]. To further improve the effect of these guidance channels, the tubes are
filled with extracellular matrix components like laminin [19], trophic factors like NGF and other
support cell types like Schwann cells. Various levels of success have been attained in this field,
but these grafts are still trailing the “gold standard” autografts.
2.2. Nerve Growth Factor and Nerve Cell Regeneration
2.2.1 Nerve Growth Factor for Neuronal Growth, Survival and Maintenance.
The presence and role of NGF as a growth promoting agent came into light in 1948 when
Bueker [20] observed innervations of fragments of mouse sarcoma 180 when they were placed in
the body of chick embryos. Basically designed to study the effect elicited by target tissues on
neurons, the study revealed one of the most important factors of nerve growth. Experimental
results showed that the neurons emerging from the embryos bearing the sarcoma were bigger in
size. This was not restricted to neurons close to the sarcoma but was also observed in distant
neurites. It was evident from the results that there was a growth promoting factor diffusing from
the sarcoma tissue into the embryo’s circulation and was causing excessive growth and long
nerve fibers. In an attempt to replicate these result in vitro [21], Levi – Montalcini and Meyer
cultured sympathetic and sensory ganglia dissected from chick embryo in a medium containing
fragment of the sarcoma 180 or 37. Observation after hours of incubation revealed dense,
fibrous, halo of nerve fibers extending out of the ganglia adjacent to the sarcoma fragments. This
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kind of growth was absent in any of the control cultures which were not supplemented with the
sarcoma fragments. These results provided testimony to the release of growth promoting factors
in vitro by the neoplastic tissues. This fibrillar halo kind of nerve growth from the explanted
ganglia became the most important factors for identifying the presence of the growth promoting
factor. Similar results were not obtained with other tumor tissues, ruling out a generalization of
growth enhancement by tumor cells.
Since it was already established that NGF is present in the target tissues and body fluids
[22], an attempt to study the effect of blocking NGF and observing its effect on neuronal cells
was carried out by Levi-Montalcini [23]. They injected newborn mice with an antiserum for
NGF. Controls were injected with normal serum. It was seen that by injecting a daily dose of
antiserum for 8 days, almost 99% of the sympathetic nerve cells were irreversibly destroyed. A
selective and permanent destruction of more than 90% of sympathetic neurons were observed in
new born mice and other new born mammals. The antiserum seemed to have specifically
affected organs and tissues related to these sympathetic neurons as all other tissues and organs
were similar in functionality as the control. Only adrenergic sympathetic cells which innervate
the male and female sex organs seemed to be resistant to the antiserum. But it should also be
noted that these neurons did not show any marked effect with the addition of NGF. LeviMontalcini and Angeletti [24] attempted to grow sensory and sympathetic neurons in medium
with and without NGF supplemented medium. The experimental results showed that just Eagles
medium and Eagles medium supplemented with 10% horse serum were inadequate for the
survival and maintenance of neurons. Addition of NGF to the above mentioned medium not only
resulted in neuronal survival but also showed enhanced neurite outgrowth when compared to the
controls.
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2.2.2 Importance of NGF in the Local Environment
While attempting to find out the importance of NGF for the survival and growth of these
nerve cells, Robert B Campenot [25] found that it is the presence of NGF in the local growth
environment, that is of primary importance. In his experiment, he had designed a three-chamber
system well separated from each other to prevent passage of contents. It was seen that the
neurites were able to cross the barrier into chambers containing a higher concentration of NGF.
On removal of NGF from the chambers in which the cells were grown, the neurites stopped
growing and at times seemed to degenerate. It was seen the growth had stopped and degenerated
even though there was NGF present in chambers where the proximal part of the neurites were
present. When NGF was removed from the chambers where the proximal part was found but
there was still NGF contained in the chambers where the distal part was found, the cells still
continued to extend and survive. This shows that the survival and growth of the extending
neurite depends on the local NGF concentration, regardless of the concentration in other areas.
This also reaffirms earlier finding that neurites seem to grow in directions where target tissues
releasing NGF are placed, rather than in the opposite direction. As the author points out, this
highlights the body’s mechanism to direct growing neurites towards target tissues. When neurites
extend in direction other than towards the target tissues, they enter a region where there is no or
very little NGF. The extending neurites stop extending and begin to degenerate even if there is
enough NGF in the proximal end of the neurite or where its somas are present.
2.2.3 Nerve Growth Factor for Enhancement of Neurite Extension
Ronald M Lindsay [26] established through a series of experiments that though NGF
enhances the regeneration and growth in sensory neurons, they are not required for the survival
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of adult sensory neurons. He cultured adult rat dorsal root ganglion sensory neurons in the
presence and absence of NGF and other neurotrophic factors. The reaction of these cells to the
presence and absence of other non neuronal cells was also observed in this study. This was to
rule out any factors secreted from the non neuronal cells from promoting neuronal cell growth. It
was observed that even in the absence of NGF and other neurotrophic factors, about 70-80% of
the cells survived. Though NGF was not seen to be necessary for the survival of the adult
sensory neurons, they seem to promote the regeneration of axons from the adult DRG neurons.
In a similar experiment, Tanaka et al [27] tested the effectiveness of NGF on 10, 72- and
114-week old mice dorsal root ganglion. From the results it was seen that though NGF
accelerated the growth of neurites in these cells, they were not necessary for the survival of the
adult DRG neurons. It was seen that the NGF was able to significantly improve neurite growth
and extension with even the 114-week old adult dorsal root ganglion proving that the growth
promoting effect of NGF does not cease with aging, but it is probably just the dependence on
NGF for survival that disappears with age.
The difference in the effect elicited by NGF in the early stages of embryonic stages was
also being studied by a few researchers. In his study of the quantitative effect of NGF on chick
dorsal root ganglion, Blood [28] used DRGs extracted from chick embryo at different embryonic
development stages ranging from E8-E14. It was seen that there was an increase in the density of
neurons in NGF treated cultures when compared to the control cultures and this effect was more
pronounced in the earlier embryonic stages compared to the later embryonic stages. It was also
seen that the number of neurons per unit area were significantly greater in the case of NGF
treated samples in the earlier embryonic stages but the difference between the treated and control
samples decreased with advancing embryonic levels. The length of the neurites extending out of
10

the neurons in samples treated with NGF was significantly greater compared to the controls in
the earlier stages of development. A 2.05 fold significant increase has been reported for cells
cultured from E10 embryonic cells. The most significant difference in the neurite length between
NGF treated and control samples was observed between E9-E11 after which the difference
started to become marginal compared to these stages.
2.2.4 Nerve Growth Factor as a Chemotactic Agent
Gundersan and Barret in their work [29] highlighted the role of NGF as a chemotactic
agent. In their experimental work, they showed that the growing axons tend to move towards a
source of higher NGF concentration. They showed that this change in direction of growth can be
brought about by a concentration gradient of even as low as 1 biological unit. They also showed
that the rate of growth of the axons was significantly greater when exposed to a higher
concentration of NGF. It was demonstrated in their experiment, that the axons growing in a
medium containing 1 BU of NGF had a growth of about 10µm in about 2 hours, whereas when a
high NGF concentration (50 BU) was placed near the growing axons, the displacement was
about 20µm within 30 minutes.
2.3 Role of Laminin in Neurite Extension
2.3.1 An Introduction to Laminin.
Laminin is a glycoprotein commonly found in the meshwork of basement membranes
like the epithelial lining surrounding the nerves and blood vessels and also underlying pial
sheaths of the brain. Apart from the basement membranes, it also occurs in the extracellular
matrix at early stages of development. It is seen to have been localized along with specific types
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of neurons of the central nervous system (CNS) and embryonic as well as adult stages. It is also
expressed in the peripheral nervous system at various developmental stage [30]. This
glycoprotein is a large multi-domained and cross shaped molecule synthesized and secreted by
cells into their ECM, where it usually interacts with receptors found on the cell surface leading to
morphological and migration variations with the cells.
2.3.2 Laminin for Enhanced Neurite Extension
The finding that laminin is localized in the basement membrane of the neuromuscular
membrane [31] and around Schwann cells in the peripheral nerve lead to the investigation of the
possible role of laminin in nerve growth. Baron-Van Evercooren et al investigated the effect of
growing nerve cells on laminin coated surfaces and compared it to the growth of neurites on
other surfaces like fibronectin and collagen [32]. Human fetal sensory ganglia cultures were
grown on three different substrates namely laminin, fibronectin and collagen in a medium
containing NGF. It was seen that of all three substrates, laminin produced the most extensive
neurite outgrowth. Neurites extending out of the ganglia on a collagen surface were radially
oriented and tended to form bundles. The Schwann cells were seen flattened under the neurites
and were later seen migrating along the neurites. Fibronectin produced more growth on the
neurites when compared to collagen and were seen spreading out radially on a heavy layer of
fibronectin. Neurites growing on fibronectin showed more branching when compared to those
grown on a collagen surface, and the Schwann cells had also migrated further. Laminin produced
more extensive growth and branching when compared to the other two substrates. The branching
was more extensive in all directions, Schwann cells were seen migrating along the neurites and
the movement of the fibroblast seemed restricted. There were no major bundles formed on
laminin like those on collagen. A study on the synergistic effect between laminin and NGF
12

revealed how these two worked together. Antibodies to NGF reduced growth to a great extent,
though this growth was greater than that on a collagen surface. Thus NGF was essential for
improvised neurite growth. Antibodies to laminin completely prevented growth on the surface in
a serum free medium, though such drastic effects were not observed in a medium containing
serum. This study showed how laminin was important for enhanced neurite extension and how
NGF and laminin acted together to have a synergistic effect on neurite extension. The growth
rate on laminin was 2.1 times that of control cultures.
2.3.3 Mechanism of Action of Laminin in Promoting Neurite Extension
To understand how laminin promotes the growth of neurites, Rivas et al [33] studied the
effect of laminin on the growth cone of the growing neurites, as the growth cone is the
specialized end of the growing neurite and thus must be a very important site of any growth
promoting compound. Earlier it was believed that glycoproteins like laminin and fibronectin
promoted neurite growth by promoting adhesion of the axons to the surface [34]. It was seen that
there was an increased surface adhesion when these glycoproteins were used, and since there was
also an increase in the neurite length, it was assumed that there was a connection between these
two factors. Further work on this showed that surface adhesion does not necessarily have to be
the factor promoting neurite extension as there was no way to prove how the adhesion helps the
neurite to extend. Later it was shown that laminin promoted the neurite extension and enhanced
adhesion to the surface, but these two effects were independent of each other and did not
influence each other [35-37]. Thus Rodolfo et al attempted to study the effect of Laminin on the
growth cone of a growing neurite. They first cultured a single rat sympathetic neuronal cell on a
polylysine coated surface and supplemented it with serum free medium. A single thick neurite
ending in a growth cone with a large lamellipodia was seen extending out of the cell. The rate of
13

extension was about 3 ± 1 µm/hr. It was seen that when laminin was added to the culture, it led
to the formation of a multiple thin outgrowths with excessive branching at a rate of about
22±2µm/hr. Though there was a difference in growth rate, the morphology of the new neurites
was similar in both cases. Since it was evident that laminin enhanced neurite extension, it was
then decided to focus on the action of laminin on the growth cone. When the growth cone was
observed on a polylysine surface, it was seen that the growth cone had a large lamellipodia and
numerous filopodia which were moving constantly. This movement consisted of extension and
retraction, especially the dorsal filopodia moving constantly towards the lamellipodia. The net
movement was very small because the number of filopodia that were extending was only slightly
greater than those retracting or staying still. Thus the overall forward movement was as slow as
4µm/hr on an average, although the extensions and retraction were themselves at about
2µm/min. This shows that there was no significant difference in the extensions when compared
to the retractions. The advancing movement of the organelles into the lamellipodium was almost
as slow as the extension of the filopodia. Addition of laminin to the culture produced a
significant decrease in the number of filopodia and veils that were retracting. The rate at which
the filopodia was extending out almost doubled, though this occurred gradually compared to the
suddenly decrease in the number of retracting cells. The most important and dramatic change
that laminin brought about to the growth cone was that the movement of the membranous
organelles from the central region into the lamellipodium. The speed at which this movement
happened was 6 times faster than laminin. This resulted in the complete filling of the original
lamellipodium with membranous organelles within 20 minutes. Other notable differences in the
growth cone 20 minutes before and 20 minutes after the addition of laminin are, the growth cone
had advanced further after the addition on laminin compared to prior to and several of the

14

filopodia became larger after the addition of laminin. Though in some cases the original neurite
proceed to grow as a single process, in most cases in resulted in the formation of multiple
neurites from the peripheral end of the lamellipodium. The moving organelles filled the newly
formed filopodia or the lamellipodia and these consolidated into neurites leading to the formation
of growth cones at the tips. This forward movement of the membranous organelles causes
forward growth of the neurites and it is a continuous process. The velocity of the filling of the
lamellipodium and hence the neurite outgrowth is faster compared to the rate of retraction and
thus there is an enhanced growth with laminin when compared to polylysine. Another finding
that substantiates the usefulness of laminin is the observation that the extended neurites are
retained longer on laminin than on other glycoproteins and growth promoting substrates [36]. It
is believed that the action of laminin is mediated by integrin which acts as cell surface receptor
and is essential for laminin to enhance the rate of neurite extension. The essential role of integrin
was established when a polyclonal antibody for the β1 subunit of integrin prevented the effects
elicited by laminin on the morphology of the growing axons [38, 39]. The action of laminin is
also selective, in the sense that it does not influence outgrowth by acting on the overall neurite,
but rather acts on the growing tip of the growth cone.
2.3.4. Laminin for Directional Orientation
Kuhn et al. [40] devised a simple experiment to understand how laminin direct neuronal
growth cones. DRG neurons were cultured on either laminin or fibronectin substrates and then
were confronted with ‘guideposts’, which were polystyrene beads coated with the alternative
substrate. That is when laminin is the substrate for culture, then fibronectin is the substrate for
‘guideposts’ and vice versa. It was seen that, if the cells are plated on a fibronectin substrate and
confronted with a laminin-coated bead guidepost, a sustained acceleration in growth following
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filopodial adhesion, dilation of growth cone, and translocation toward the laminin-coated bead
could be observed. This acceleration in growth rate is sustained even beyond the guidepost. On
the other hand, when cells are plated on a laminin substrate and filopodia contacted fibronectincoated beads, then the cells experience a sustained deceleration in growth to that of fibronectin
basal level. It was also seen that when the carboxyl terminal region of laminin is exposed on the
guidepost bead, acceleration in growth cone navigation occurs on fibronectin substrate. An
antibody pretreatment of laminin-coated guideposts nearly abolishes this acceleration thus
pointing out the significance on the carboxyl terminal in directing the accelerated growth. The
interactions between growing tips of neurites and laminin substrates or other ECM molecules are
stereotypic and initiated by individual filopodia which thus detect a substrate on a guidepost and
direct behavior even before growth cone behavior changes. The nature of the coating on
guideposts is irrelevant for filopodial sampling, but a receptor–ligand interaction is required for
long-term adhesion to the guidepost. Intracellular signaling is required for transduction of
guidepost cues, since low concentrations of an inhibitor of protein kinases (protein
serine/threonine kinase A and G, and calcium-dependent protein kinase C) reduce the number of
growth cones responding even though the filopodial sampling and contacts appear normal. This
result suggests that laminin model guidepost cues depend on protein kinase-dependent pathways
for transduction of the laminin signal to the cytoskeletal apparatus
2.4. Retinoic Acid and Nerve Cell Regeneration
2.4.1 Retinoic Acid for Enhanced Neurite Extension
Neil Sidell, Quinn, De Boni and Haskell were amongst the earliest people to study the
effect of retinoic acid (RA) on nerve cell regeneration. Sidell was apparently the first person to
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report the neurite outgrowth enhancement capability of RA in his study on the effect of RA on
the growth and differentiation of human neuroblastoma cells in vitro [41]. He reported a dose
dependent response in both the growth inhibition and morphological differentiation in the cells.
From his results it was seen that RA showed increasing growth inhibition with increasing
concentration. RA prevented cells from growing colonies on the agar surface on which they were
seeded. Though there was inhibition of growth of the cells, there was no decrease in the viable
cell count when compared to the control culture to which no RA was added. This suggested that
RA inhibited any cell proliferation, but at the same time maintained the viability of the cells. An
interesting outcome of this experiment was the morphological differentiation that the cells
underwent upon treatment with RA. A large number of cells produced long neurites, maximum
growth being observed in the concentration between 10-5M and 10-6M.
Quinn et al [42] attempted to study the effect that RA had on a culture containing
different types of neuronal cells from neonate murine DRGs and fetal spinal cord and also from
fetal human spinal cord explants. They also compared the results of using various concentration
of RA ranging between 100µM to 1nM to find out the most optimal concentration of RA that
produces maximum possible enhancement. From the results they were able to establish that RA
primarily acted by increasing the mean neurite length and not the number of neurites. The results
showed that RA produced a significant increase in neurite outgrowth length when compared to
the controls. All the concentration studies produced an enhanced effect when compared to the
controls which did not have RA in their growth medium. With respect to dorsal root ganglion
neurons, it was found out that the effect of RA was more predominant at 10µM than the higher
or lower concentrations. The neurite outgrowth enhancement at this concentration ranged
between 18.1% to about 47.5% with a mean of about 30.7% over a period of 11 days through
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which the cultures were observed. Though the enhancement noticed at other higher and lower
concentrations tested was not as optimal as with 10µM, they were significantly greater than the
control cultures. Enhancements of over 133% with respect to controls were also observed in a
few cultures at this concentration. With the help of the representative length distribution
histograms, they were able to conclude that RA acted primarily by increasing the length of most
of the neurites in the population rather than acting on subset cells. In the case of fetal mouse
spinal cord neurons, the optimal concentration of 10µM for DRGs produced an inhibitory effect
in the fetal neurons. Inhibition of up to 12% was observed at 10µM for fetal mouse spinal cord
neurons. At lower concentrations of 1µM and 0.01µM, RA was able to produce maximum
outgrowth with fetal mouse spinal cord neurons. In the case of human fetal spinal cord neurons,
optimal RA concentration for growth enhancement was 10µM and 0.1µM. From the data they
observed that there was a dose dependent shift in mean length for the entire population and not a
specific sub population and this helped them conclude that RA primarily acted by increasing
mean neurite length rather than by increasing neurite sprouting. Though Haskell et al [43]
observed optimal growth at 1 to 0.1µM with chick DRG, the growth was insulin dependent. But
irrespective of the concentrations used, RA was found to produce enhanced neurite growth.
2.4.2. Retinoic Acid elevates NGF Receptor Concentration
Haskell et al [43] attempted to examine the effects of RA on cell surface receptors for
NGF, since RA is known to have the capacity to modify glycoprotein synthesis. RA produced
extensive extension in neurite length at the end of 4 days with 10-5M with LA-N-1 human
neuroblastoma cells. The morphology of the cells treated with RA was not very different from
the morphology of cells treated with NGF. RA did not produce any morphological changes to the
cells. They reported that RA produced a decrease in viable cells at the end of the 4 day treatment.
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But the major aim of this study was to see if RA causes any significant increase in the number of
receptors for NGF. An immune assay performed for NGF revealed intense fluorescence with RA
treatment.

There

was

rarely

any

fluorescence

observed

without

RA.

Since

the

immuneflourescence assay had the disadvantage that there could be non-specific binding of
NGF, Haskell et al used soluble LA-N-1 cells with

125

I-NGF to validate that RA increased the

number of receptors of NGF. Experimental results showed that retinoic acid produced a 7 to 11
fold increase in the number of high affinity receptors for NGF and a 3 – 8 fold increase in the
number of low affinity receptors. These results clearly showed that RA induced an increase in
the number of NGF receptors apart from producing enhanced neurite extension.
In a similar kind of study, Scheibe et al [44] attempted to study the effect of RA on clonal
PC12 cells derived from rat pheochromocytoma. The main aim of the study was to see the effect
of RA on NGF receptors on the cell surface, and this was done by tracking p75NGFR which is a
NGF receptor (NGFR). It was seen from the results that within 3 hr of addition of 1µM of RA,
the expression of p75NGFR mRNA doubled and by the end of 12 hrs it was more than 3 times its
initial value. It was seen that this level of elevated receptor concentration was maintained for
about three days. In an attempt to determine if high level of p75NGFR mRNA was caused by
modulations to the stability of the mRNA or by increased transcription, the half-life of the
mRNA from control and cells treated with RA was compared after 8 hours. It was seen that the
half-life of the control and the treated group was not significantly different, pointing out that the
RA acted more through transcription rather than by just merely causing mRNA stability. To
further determine if RA increased the binding of NGF to the cells, a Scatchard plot analysis was
performed using

125

I-NGF. It was seen that pretreatment with RA increased the number of low

affinity binding sites by up to 3 folds, but no significant increase in the levels of high affinity

19

binding sites were noted. It was seen that there was no significant increase in this level after 24
hours. It was concluded that in the case of PC 12 cell line, RA increased the number of low
affinity receptors.
2.4.3 Retinoic Acid for Nerve Cell Survival
Apart from enhancing the extension of neurites, it was also found out that RA is essential
for the survival of neurons at early embryonic stages. This was established by Rodriquez al [45]
when they cultured sympathetic neurons with NGF and RA. It was seen that the neurons from E7
(Embryonic development day 7) were not able to survive in a medium supplemented with just
NGF and not any RA. Neurons from E7 embryos were able to survive when supplemented with
both NGF and RA. Cells from later stages (E8 onwards) were able to survive in the presence of
just NGF. Since it was already established that RA increases the number of receptors for NGF,
they attempted to see if RA was essential for neuronal cell survival at earlier embryonic
development stages. It is known that there are two kinds of receptors for NGF, a low affinity (Kd
2X10-9 M) receptor and a high affinity receptor (Kd 2X10-11M) [46]. A steady state binding study
carried out with E7 sympathetic neurons showed the presence of low affinity receptors but no
detectable amounts of high affinity receptors. Since it is a prerequisite for NGF receptors to be
presenters for the cell to be NGF responsive and because the cells had survived in the presence
of NGF and RA, experiments were carried out to see if RA induced any NGF receptors.
Experimental results showed that only the cells cultured in the presence of RA showed detectable
amounts of the high affinity receptors and these cells were also able to survive. Since the low
affinity receptors are fast dissociating, they were not able to elicit any response to NGF. The
induction of high affinity receptors by RA made the cells NGF responsive and this helped them
survive in the culture. The neuronal cells attain high affinity receptors on their own with
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embryonic development. It was seen that cells from later stages of development exhibited
detectable amount of the high affinity receptors, and these cells were able to survive in the
presence of NGF alone. It should be noted that earlier works had reported survival of cells in
culture mediums containing just NGF [24]. It should be noted in this particular reference that the
cells did not survive when they were grown in eagles medium supplemented with horse serum,
but survived when NGF was added to it. It is to be noted that there is a substantial amount of alltrans RA present in serum. The exact amount of RA present in horse serum is currently
unknown, but there is a substantial amount of RA present in the serum of animals, about 0.01623
µM in humans and about 0.0067µM in rat serum [42]. This RA concentration in plasma falls
within the range of RA concentration that can induce cell survival and growth.
The key role of RA for neurite survival was further established by Plum et al [47]. In his
study he not only explains the importance of the presence of RA during earlier embryonic stages,
he also affirms the necessity for continued presence of RA. They cultured DRG from chick
explants from different embryonic stages with and without all-trans retinoic acid in a culture
already supplemented with NGF. They found that, apart from NGF, all-trans RA was also
essential for the survival of cells explanted from embryos at early development stages between
6.5-7 days. Their data showed that unless both NGF and all-trans RA were present, most of the
cells were dead, showing that both NGF and RA was essential for long term survival of cells at
this embryonic stages. At later level of embryonic development (7.5 – 11 days) RA was not
essential for the survival of cells, though the presence of RA enhance the neurite outgrowth from
the cells. Thus they were able to show that RA can produce enhanced neurite extension at all
ages. Even at the later stages of embryonic development, NGF was essential for the survival of
the cells, the absence of which caused the cells to perish. This reinstated the finding by others
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about the requirement of NGF for neuronal cell survival. Plum et al also recorded another
interesting change to the culture when RA was removed from the culture, upon which the
neurites started to decrease in length and disintegrate, leaving behind tracks through which they
had previously extended into. They were thus able to conclude that RA was necessary for the
maintenance of the extended neurites to survive.
2.4.4. Mechanism of Action of Retinoic Acid
RA is known to act both in an autocrine and paracrine manner. RA can be enzymatically
metabolized from retinol in target cells or it can directly enter the cell from the plasma. In blood
it is usually transported as retinol bound to a retinol binding protein (RBP) This RBP retinol
complex is taken up by the cells and converted to RA. RA then attaches to the Retinoic Acid
Receptor (RAR) / Retinoid X Receptor (RXR) complex. It then attaches to the Retinoic Acid
Response Element (RARE) found in the promoter region of the target gene. The mechanism has
been schematically represented in Figure 2.
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Figure 2 Mechanism of action of retinoic acid. Adapted from [48]
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CHAPTER 3: MATERIALS AND METHODS

3.1. Materials
3.1.1. Reagents
NGF stock solution was prepared by dissolving 10µg of NGF in 100 ml of sterile PBS.
50µl of this solution was dissolved in 950µl of sterile PBS, and the resulting solution was split
into aliquots of 0.5ml and stored at -80⁰C. It should be noted that all pipette tips and eppendorf
tubes used were pre-coated with bovine serum album (BSA) to minimize NGF adsorption onto
the surfaces. NGF from these aliquots was used in the final reaction mixture. These aliquots were
also coated with BSA for the above mentioned purpose.
RA stock solution was prepared by dissolving 2.3mg of RA in 700ml of absolute ethanol.
This was divided into 5 tubes. 10µL of this stock solution was dissolved in 990µl of
NEUROBASAL™ Medium (1X) (Invitrogen) to give a solution of 10-4M concentration. This
was used as the stock solution. The eppendorf tubes containing the stock solution were covered
with aluminum foil because RA is light sensitive. The stock and aliquots containing the RA
solution were stored at -80⁰C.
Uridine stock solution was prepared by diluting 0.01875 g of Uridine in 10.7 ml of PBS.
This was then split into 10 aliquots of 1 ml each with a concentration of 1.75mg/ml. FDU (5fluro-2-deoxyuridine) stock solution was prepared by dissolving 0.00809g of FDU powder in
10.8 mL of PBS. This gives a stock solution of 0.075mg/ml. This was divided. into 10 vials of
1ml each. Both FDU and Uridine were covered with aluminum foil because they are slightly
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light sensitive. Uridine and FDU were added to prevent the proliferation of non-neuronal cells
(e.g. Schwann cells).
3.1.2. Substrate Preparation
A PLL stock solution of 0.1mg/ml was prepared by diluting 25mg of Poly-L-Lysine
hydrobromide in 250 ml of sterile Phosphate Buffer solution and stored at -20⁰C
Laminin stock solution was prepared by diluting 1mg of laminin (BD Biosciences; cat.
no. 354232) in PBS to attain a final concentration of 1mg/ml. This was split into smaller aliquots
of 0.5ml eppendorf tubes and stored at -80⁰C. The aliquot tubes were first pre-coated with BSA
solution which was prepared by dissolving 50µg of BSA (Sigma Aldrich) in Distilled water. The
aliquots are coated with BSA so as to prevent the laminin from attaching to the surface of the
eppendorf tubes, which will lead to a reduction in the concentration of laminin in the solution,
which would decrease the protein concentration in the final culture. The concentration of laminin
that was used for substrate coating is 50µg/ml and this was prepared by diluting 100µl of laminin
stock solution in 1900 ml of sterile PBS.
3.1.3. Culture Medium
A 50mL stock solution of the Neurobasal Culture medium was prepared by mixing
48.375mL of NEUROBASAL™ Medium (1X) (Invitrogen; Gibco 21103-049), 1mL of B-27
Supplement (Gemini Bioproducts, Calabasos, CA, USA; cat. no. 400-160), 500µL of Penicillin
Streptomycin (Invitrogen Corp./Gibco, cat. no. 15140-122) and 125µL of L-Glutamine. This
Neurobasal culture medium was stored at 4⁰C.
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3.1.4. Eggs
Fertilized chicken eggs were obtained from The University of Tennessee Agricultural
Experimental Station. The eggs were stored at 12⁰C and were then incubated at 100⁰F until they
reached the desired embryonic stages. The eggs were placed on an automatic tilter to ensure
proper shaking and the incubator was also supplemented with air and water to maintain
appropriate humidity inside the incubator.
3.2. Experimental Protocols
3.2.1. Substrate Coating
3.2.1.1. Poly-L-Lysine Coating
The custom prepared well inserts were soaked in 70% ethanol for 30 minutes and then
washed twice with fresh 70% ethanol and then allowed to air dry. The air dried wells were
washed in sterile deionized water and allowed to dry for a few minutes. The wells were then
loaded with 100µl of 0.1mg/ml PLL and left undisturbed overnight for approximately 12 hours.
Afterwards, the PLL from the wells was removed, and the wells were washed thrice with sterile
water. This is performed to remove any excess PLL because extra PLL may be inhibitory to cell
survival. After washing with sterile distilled water, the wells were air dried for a few minutes.
3.2.1.2. Laminin Coating
To ensure uniform laminin coating requires the wells to be pre coated with PLL. Before
applying the laminin coating, the PLL-coated wells were washed and air dried as described
above. 100µl of 50µg/ml laminin was then added to the wells and allowed to stand for about 1hr.
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These wells can either be left in an incubation chamber maintained at 37⁰C, or left over in the
laminar hood. After 1 hr of incubation, the laminin solution from the wells was removed. After
the laminin was completely removed, the wells were washed with sterile water to remove any
excess laminin, as excess laminin can promote biased directional growth towards it, which may
skew the data.
3.2.2. Embryo Dissection
Eggs between the embryonic developments stages 9 – 11 were used for this purpose.
DRGs were explanted from chicken embryo between the embryonic stages E9-E11. A way of
checking if there is an embryo in the incubated egg is by holding it against the flash light in a
dark room. If a thin vasculature is to be spotted on the wall of the shell, it is an indication that the
egg might have an embryo. Another possible indication of the presence of an embryo is the
appearance of two dark spots when viewed with the flash light. These two spots are actually the
eyes of the embryo.
Though there might be a possible indication for the presence of embryo within an egg,
the possibility that the embryo is not formed or is deformed exists. The embryo can be removed
from the egg by carefully cracking open the broader side of the eggs as illustrated in Figure 3.
The arrow head shows the zone where the egg can be typically cracked open. We crack the
broader size of the embryo because the air gap is greater at this side and this makes it easier to
crack the egg without damaging the embryo. All tweezers and tongs used in the dissection
process are sterilized using 70% ethanol before the dissection process. The tweezers are used to
break the membranes and reach for the embryo. Once the embryo is removed from the eggs, it is
placed in a petridish plate containing HBSS (Hanks balanced salt solution). This plate is placed
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Figure 3 Sketch of a typical E10 egg (Adapted from science-art.com)
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on ice so as to maintain a low temperature. This helps maintain the viability of the cells until it
has been explanted and transferred to the culture plates. The whole dissection process is always
carried out while the embryo is immersed in HBSS. The embryo is cut open from the top side
and the organs are carefully removed. The DRGs can be seen on either side of the spine. They
are carefully explanted and placed onto a petridish plate containing HBSS. The explanted DRGs
are split into half so as to remove the surrounding membrane which inhibits sprouting of the
neurites. These split DRGs are used in the cell culture.
3.2.3. Nerve Growth Factor Concentration Determination
The explanted DRGs were cultured on 2 sets of PLL coated wells and two sets of PLL
and laminin coated wells. Each well was supplemented with the culture medium, 17.5µg/ml
Uridine and 7.5µg/ml FDU. 1ng/ml of NGF was added to one set of PLL coated wells and
50ng.ml of NGF was added to the other set of wells. Similarly 1ng/ml of NGF was added to one
set of wells coated with both PLL and laminin and 50ng/ml was added to the other set. These
cells were incubated at 37⁰C for 36 hrs.
3.2.4. Cell Culture Conditions.
3.2.4.1. Control Groups
The basic control group consists of DRG cultured with the culture medium, 17.5µg/ml
Uridine and 7.5µg/ml FDU on PLL coated wells with no additional growth enhancement
molecules. A second control group has DRGs cultured under similar experimental conditions but
on wells with an additional laminin coating.
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3.2.4.2. Nerve Growth Factor as a Single Agent
DRGs were cultured in the culture medium supplemented with 50ng/ml NGF, 17.5µg/ml
Uridine and 7.5µg/ml FDU, on PLL coated custom prepared wells. These were incubated at
37⁰C for 36 hours.
3.2.4.3. Nerve Growth Factor with Laminin
DRGs were cultured in the culture medium supplemented with 50ng/ml NGF, 17.5µg/ml
Uridine and 7.5µg/ml FDU, on wells which have an additional laminin coating. These were
incubated at 37⁰C for 36 hours.
3.2.4.4. Retinoic Acid as a Single Agent.
DRGs were cultured in the culture medium supplemented with 1µM RA, 17.5µg/ml
Uridine and 7.5µg/ml FDU on PLL coated wells. The petridish plated containing the cultures
were covered with aluminum foil to prevent degradation of RA. These were incubated at 37⁰C
for 36 hours.
3.2.4.5. Retinoic Acid with Laminin
The DRG cells were cultured in the culture medium supplemented with 1µM RA,
17.5µg/ml Uridine and 0.75µg/ml FDU on custom prepared well plates which have an additional
laminin coating apart from the PLL coating. The petridish plated containing the cultures were
covered with aluminum foil to prevent degradation of RA. These were incubated at 37⁰C for 36
hours.
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3.2.4.6. Nerve Growth Factor along with Retinoic Acid.
DRGs are cultured in the culture medium supplemented with 50ng/ml NGF, 1µM RA,
17.5µg/ml Uridine and 7.5µg/ml FDU on PLL coated wells. The petridish plated containing the
cultures were covered with aluminum foil to prevent degradation of RA. These were incubated at
37⁰C for 36 hours.
3.2.4.7. Nerve Growth Factor, Retinoic Acid and Laminin
The DRG cells were cultured in the culture medium supplemented with 50ng/ml NGF,
1µM RA, 17.5µg/ml Uridine and 0.75µg/ml FDU on custom prepared well plates which have an
additional laminin coating apart from the PLL coating. The petridish plated containing the
cultures were covered with aluminum foil to prevent degradation of RA. These were incubated at
37⁰C for 36 hours.
The reaction mixtures were designed in such a way that it would be possible to test the
individual effect of a single component on the growth of neurites, as well as the synergistic effect
of any two compounds and that of all the compounds together. This would help us to compare
and evaluate if any difference exists between the reaction conditions and if so the significance in
the difference and the possible advantages. All the experimental condition can be summarized as
a tabular column as follows.
3.2.5. Delayed Release Study
To test the significance of the time of addition of NGF to the culture, NGF was added at
different time points and the neurite growth was examined for all the reaction conditions. The
DRG cells were cultured in the culture medium supplemented with 1µM RA, 17.5µg/ml Uridine
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and 0.75µg/ml FDU on custom prepared well plates which have an additional laminin coating
apart from the PLL coating. The petridish plates containing the cultures were covered with
aluminum foil to prevent degradation of RA. NGF was added at 0 hours, 12 hours and 24 hours
after the initial addition of culture medium. These were incubated at 37⁰C for 36 hours.
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Table 2 Reaction conditions

SUBSTRATE

URIDINE

FDU

NGF

RA

CONDITION 1

PLL

17.5µg/ml

7.5µg/ml

--

--

CONDITION 2

PLL

17.5µg/ml

7.5µg/ml

50ng/ml

--

CONDITION 3

PLL

17.5µg/ml

7.5µg/ml

--

1µM

CONDITION 4

PLL

17.5µg/ml

7.5µg/ml

50ng/ml

1µM

CONDITION 5

PLL+LN

17.5µg/ml

7.5µg/ml

--

--

CONDITION 6

PLL+LN

17.5µg/ml

7.5µg/ml

50ng/ml

--

CONDITION 7

PLL+LN

17.5µg/ml

7.5µg/ml

--

1µM

CONDITION 8

PLL+LN

17.5µg/ml

7.5µg/ml

50ng/ml

1µM
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3.3. Image Acquisition and Data Processing
3.3.1 Image Acquisition.
All the wells were imaged using an Olympus inverted phase contrast microscopy at 4X
magnification. The images were acquired using a Nikon camera attached to the microscope and
were processed using Wasabi. All images were obtained as 8-bit images of 1000 X 1000 pixels.
3.3.2. Image Processing and Data Collection
The images were processed using ImageJ (Wayne Rasband, National Institute of Health,
Bethesda, MD) software and MATLAB 7.0 (Mathworks, Cambridge MA). For analysis of the
length, 10 of the longer neurites were chosen at random. This was done manually by a blindfold
mechanism, where a volunteer not associated with the project were asked to pick 10 neurites
which they thought were the longest. They were not given any reaction condition details or any
information about the study. The segmented line selection of ImageJ was used for measuring the
length of the neurite outgrowth. This allows tracing the distance between various points. The
outgrowth of the neurite was traced from the cell tip till its distal end (Figure 4). All values are
obtained in pixels and are then converted into micrometers. The normalized area was calculated
by measuring the overall area of coverage and subtracting the area occupied by the cell body
from that value (Figure 5). Freehand selection of ImageJ was used for measuring the area
occupied by the neurites and by the cell. The values were obtained in pixels and then converted
to micrometers. The enhancement of image quality of quantification was carried out using
various features in ImageJ and MATLAB.
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Figure 4 Length measurement using ImageJ
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Figure 5 Normalized area measurement using ImageJ
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3.4. Statistical Analysis
All statistical analysis was conducted in JMP (JMP 6.0 SAS Institute, Cary, NC). Seventy
longest neurites from each condition were considered for data analysis. A univariate analysis was
performed to test for significance at p ≤ 0.05. A post-hoc Tukey’s test was performed for
conditions where significant difference was noted.
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CHAPTER 4: RESULTS

4.1. Nerve Growth Factor Concentration Study
A study between the effect of two different NGF concentrations of 1ng/ml and 50ng/ml
revealed that 50ng/ml produced more clearly defined neurite outgrowth when compared to
1ng/ml. Though a lot of cellular material was seen spreading around the cells treated with 1ng/ml
NGF, the actual length of the neurite was significantly less (p ≤ 0.05) than the neurite extension
that was achieved with 50ng/ml (Table 3). The growth with 50ng/ml was more than twice of
what was achieved with 1ng/ml (Figure 6).
Table 3 Neurite extension at different NGF concentrations
Concentration
NGF 1ng/ml
NGF 50ng/ml

Mean ± SD
289.564 ± 22.2169
594.495 ± 45.343

Figure 7 depicts the effect of 1ng/ml and Figure 8 represents the growth achieved at
50ng/ml. It can be seen that at 1ng/ml the spreading of cellular material is more profound
whereas formation of defined neurites is minimal. Comparatively with 50ng/ml clearly defined
neurites can be seen arising from the cell body. It can also be seen that with 50ng/ml the growth
of the neurite is very clear, defined and directional.
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Figure 6 Nerve growth factor concentration determination study
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Figure 7 Nerve growth at 1ng/ml
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Figure 8 Nerve growth at 50ng/ml
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4.2. Study of Neurite Extension
Varying levels of extension were observed when Dorsal Root Ganglion (DRG) cells were
cultured for 36 hours using all the reaction conditions discussed earlier. The growth obtained
using NGF, RA and laminin (triple component system) together was significantly greater
(p ≤ 0.05) than the extension observed in cultures using any other reaction condition. Figure 11
compares the mean neurite length of the triple component system with all the other reaction
conditions. Figure 12 illustrates the percentage difference in growth between the triple
component system and all the other reaction conditions. The growth obtained with the triple
component system was 1047.79±112.11µm and was almost 5.4 times of Control 1 (PLL alone)
and around 2.5 times of that obtained with Control 2 (PLL+LN). Table 4 list the mean neurite
length in µm achieved with each reaction condition. The triple component system also produced
significantly greater neurite extension (p ≤ 0.05) when compared to the best growth achieved by
a double component system (laminin and RA). A significant difference in growth (p ≤ 0.05) was
observed between most of the reaction conditions. Extension of neurites on PLL substrate was
the least. When NGF was present in the culture the extension was significantly greater than that
observed with just PLL. The extension with NGF alone was also significantly greater than the
extension observed with laminin alone. RA produced a greater level of extension when compared
to either NGF or laminin. Absence of significant difference was only noted in the following two
cases. The extension obtained using NGF and RA on a PLL substrate was not significantly
different from that observed when NGF was used with a laminin substrate. Likewise there was
no significant difference in the extension produced when RA was used on a PLL substrate and
when NGF was used on a laminin substrate. Figures 9 and 10 illustrate the mean neurite length
for each reaction condition. Figures 13-20 represents the growth achieved for each condition.
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Table 4 Neurite extension for various reaction conditions
LENGTH (μm)
CONDITION
MEAN ± SD
PLL

194.6 ± 23.94

PLL+NGF

528.23 ± 51.68

PLL+RA

738.74 ± 185.82

PLL+NGF+RA

793.3 ± 110.57

PLL+LN

416.15 ± 106.44

PLL+LN+NGF

768.24 ± 93.18

PLL+LN+RA

927.5 ± 83.55

PLL+LN+NGF+RA

1047.79 ± 112.11

43

1000

*

*

Average Maximum Neurite Length (μm) at 36 hours

900

800

700

*
600

500

400

300

*

200

100

0
PLL

PLL+NGF

PLL+RA

PLL+NGF+RA

Figure 9: Average maximum neurite extension on PLL substrate
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Figure 10 Average maximum neurite extension on laminin substrate
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Figure 11 Comparison of neurite extension with triple component system
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Figure 13 Nerve growth on treatment with PLL
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Figure 14 Nerve growth on treatment with NGF
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Figure 15 Nerve growth on treatment with RA
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Figure 16 Nerve growth on treatment with both NGF and RA
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Figure 17 Nerve growth on treatment with laminin
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Figure 18 Nerve growth on treatment with NGF and laminin
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Figure 19 Nerve growth on treatment with laminin and RA
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Figure 20 Nerve growth on treatment with NGF, laminin and RA
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4.3. Area of Outgrowth
A significantly greater area of outgrowth was achieved by using the triple component
system in comparison with all other reaction conditions. Table 5 lists the area of outgrowth
achieved with six reaction conditions. The cultures containing only RA were not taken into
consideration for this study as RA in the absence of NGF only produced a small number of
neurites but these were substantially long. Since the actual area of coverage would be
significantly different from the area of outgrowth, these two conditions were omitted to avoid
biased data. Least area of coverage was obtained with PLL alone, which is the control.
Comparing to the control condition, presence of NGF increased the area of coverage by
approximately 22 folds, whereas coating with a laminin substrate increased the area of outgrowth
by approximately 11 folds (Table 5). The triple component system increased the area of
outgrowth by 60 folds. Figure 21 illustrates the significant difference in normalized area of
outgrowth between the different reaction conditions being studied (lack of significance between
conditions is denoted by a symbol ‘a’ in the graph). Figure 22 illustrates the area of outgrowth of
various reaction conditions with respect to the triple component system.
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Table 5 Area of neurite outgrowth
NORMALIZED AREA (µm²)
CONDITION
MEAN ± SD

PLL

17673 ± 6316

PLL+NGF

390152 ± 18725.6

PLL+NGF+RA

546888 ± 52779.8

PLL+LN

195168 ± 30066.7

PLL+LN+NGF

583820 ± 77365.3

PLL+LN+NGF+RA

1060919 ± 81365.3
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Figure 21 Normalized area of neurite outgrowth
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4.4. Time Delayed Release Study
The neurite growth observed with cultures where there was a delayed dose of NGF was
significantly smaller when compared to the culture where NGF was added initially. There was no
significant difference in growth when comparing the cultures where NGF was added after 12
hours and 24 hours after initial treatment with RA. In Figure 23, ‘a’ indicates absence of
significant difference. It is seen that the length observed with a delayed addition of NGF is
similar to the PLL+LN+RA in the main study (Figure 10).
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Table 6 Time delayed release study

LENGTH (μm)
CONDITION
MEAN ± SD

LN+RA+NGF(t24h)

938.43 ± 29.0166

LN+RA+NGF(t12h)

923.55 ± 49.1367

LN+RA+NGF(t0)

1067.65 ± 24.5531
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Figure 23 Time delayed release study
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LN+RA+NGF(t0)

CHAPTER 5: DISCUSSION

The addition of NGF to control culture significantly improved both the area of outgrowth
and neurite length. Similar results have been observed with previous experiments. This
difference in outgrowth and neurite extension can be attributed to the growth promoting activity
of nerve growth factor. It was also observed that the number of cells surviving in the presence of
NGF were greater compared to conditions where NGF was absent. This illustrates the
importance of the presence of NGF in the culture not only for the enhanced growth of the cells
but also for the survival of the cells. Laminin was able to produce neurite outgrowth in the
absence of NGF. This substantiates the fact that laminin can support cell growth on its own. The
exact mechanism by which laminin is able to help the cells survive is not well documented.
Though the cells survive on a laminin substrate even in the absence of NGF, the growth achieved
in the presence of NGF with laminin substrate is significantly greater compared to controls
without NGF. Laminin produced greater outgrowth compared to PLL because of the fact that
laminin is a better substrate for the neurites to adhere and it also promotes rapid forward
movement in the growth cone.
RA produces long neurites on both PLL and laminin substrate, but the number of neurites
is much smaller. The addition of NGF to a culture containing RA increases the number of
neurites growing out of a cell. This may be due to the fact that retinoic acid increases the number
of cell surface receptors for NGF. This means that more neurites extend out of the cells thereby
increasing the area of coverage and the area of outgrowth. RA also increases the growth achieved
with NGF. This is probably mainly an intracellular mechanism, where receptors for RA trigger a
transcriptional process for enhancing neurite growth achieved by NGF.
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A few synergistic steps could have been involved in achieving the enhanced neurite
extension that was observed with the triple component system. Laminin as a substrate would
have initially aided in proper adhesion of the cell. The presence of NGF helped in the survival of
the cells and also initiated neurite extension. Laminin aided the neurite extension by rapidly
increasing the forward movement of intracellular material in the growth cone. RA acted on the
transcription machinery, increasing the number of receptors for NGF and also on the extension
on the neurite. All the components acted synergistically with one another to produce the
enhanced neurite extension.
The time delayed release study was based on the fact RA increases the number of
receptors for NGF and these receptors would be active for 30 hours [44]. The study was designed
to observe if addition of NGF to a solution containing pre activated NGF receptors would help
achieve better outgrowth. The results showed that the extension achieved with the delayed
addition of NGF was similar to the one containing just RA. There are a few possible reasons for
why the delayed addition of NGF did not produce significant outgrowth. One of the most basic
reasons that cannot be sidelined would be experimental errors. There are chances that the
addition of NGF at a later stage was not properly devised and failed in the proper mixing of NGF
to the reaction mixture. Though the experiment was carried out carefully to ensure proper
mixing, chances of errors still exist. Another possible reason could be the amount of time given
to the cultures with delayed addition of NGF. In the condition where NGF was added after 12
hours and 24 hours, they were incubated with NGF for only 24 hours and 12 hours respectively.
This could also mean that enough time was not given for NGF to elicit its effect. This is based on
a pilot study carried out by us to determine the best optimal imaging time. We observed a
significant difference in the neurite growth between 24 hours and 48 hours. NGF had at times
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shown minimal growth at 24 hours, but even after 48 hours the growth was significant. Thus
there is a possibility that enough time was not given to the delayed addition cultures. Another
possible reason could have been the fact that the receptors for NGF could have been present but
might not necessarily be active. Previous works had only shown that the immune labeled
receptors could have been observed for 30 hours, but this does not necessarily mean that these
receptors might be active. There exists a possibility that these receptors were inactivated but
continued to persist in the medium. Since no literature ha substantiated this, future experiments
have to be designed to confirm this.
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CHAPTER 6: SUMMARY AND FUTURE WORK

The main purpose of the thesis was to verify a multi-component system could
synergistically work in order to enhance the neurite extension and neurite outgrowth. A three
component reaction mixture was designed and experiments were performed to verify that the
effect elicited by these three components together is significantly greater compared to that
elicited by the components individually or in combination with just another component.
Experimental results showed that the triple component system produced significantly greater
neurite extension and outgrowth compared to all other reaction conditions.
This thesis reveals a new dimension for enhanced neurite extension by the use of a
combination of compounds. This could mean that any growth enhancement compound could be
potentially used in combination with essential compounds to achieve enhanced neurite growth.
This gives ample scope for researchers to test alternate compounds and their effect on nerve
growth. The greater outcome of the whole thesis would be the implementation of the reaction
model into a nerve guidance conduit. The experiment clearly identifies and associates each
compound with a specific function relative to a guidance channel. This means that future
research can look at alternate sources of functionally related compounds and test their
significance on nerve growth. This will lead to the design of an efficient nerve guidance conduit.
The outcome of this thesis opens up a large number of areas of experimental scope for the
future. The concentrations of the components used here were based on earlier works. But these
compounds were used individually in earlier works. This means that there is a scope for a more
optimal concentration when these compounds are used synergistically. One such study could try
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to optimize the concentration of all the components for better enhancement of nerve extension.
Studies can also concentrate on the time delayed release study. Future experiments can be carried
out at various time points instead of 12 hours and 24 hours. There is also scope for adding RA at
a later stage instead of NGF.
Future experiments could also concentrate on adding an alternative growth enhancing
component instead of the components used here or try the effect of a fourth component on this
system and see if the growth can be further enhanced.
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